Kyle Bass files ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA Hedge Funds Short Sales Trader Talk

Baird Remains Buyers of Biogen (BIIB) Despite Kyle Bass Tecfidera ChallengeApril 22, 2015 3:50 PM PLEGRIDY® (Peginterferon Beta-1a) Three-Year Data Presented at AAN Annual Meeting Support Long-Term Safety and Efficacy in Multiple Sclerosis PatientsApril 21, 2015 7:30 AM International Survey from Biogen Identifies Opportunities for Improving MS Treatment SatisfactionApril 21, 2015 7:30 AM Biogen Idec (BIIB) Announces Significant Data from TECFIDERA in MSApril 20, 2015 7:31 AM TECFIDERA® (Dimethyl Fumarate) Data Reinforce Strong, Sustained Efficacy for Newly-Diagnosed MS PatientsApril 20, 2015 7:30 AM